Bravatek Solutions (BVTK) 10-K 5 Aug 15 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Mar. 31, 2015	Aug. 04, 2015	Jun. 30, 2015
Document and Entity Information
Entity Registrant Name	eCrypt Technologies, Inc.
Document Type	10-K
Document Period End Date	Mar. 31, 2015
Amendment Flag	false
Entity Central Index Key	1,449,574
Current Fiscal Year End Date	--03-31
Entity Common Stock, Shares Outstanding		213,863,543
Entity Public Float			$ 1,038,443
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Mar. 31, 2015	Mar. 31, 2014
CURRENT ASSETS
Cash	$ 203,072	$ 15,504
Prepaid expenses	40,105
Note receivable	59,204
TOTAL CURRENT ASSETS	302,381	$ 15,504
LONG TERM ASSETS
Property and equipment, net	6,340	$ 7,826
Intangible assets, net	57,110
TOTAL LONG TERM ASSETS	63,450	$ 7,826
TOTAL ASSETS	365,831	23,330
CURRENT LIABILITIES
Accounts Payable and Accrued Liabilities	157,249	26,180
Accounts Payable - Related Party	13,200	13,200
Accrued Interest	82,956	85,816
Accrued interest on loan-related party	267,960	193,764
Notes Payable - Related Party	558,500	553,000
Notes Payable	430,788	$ 659,854
Convertible notes payable net of discount	166,568
Derivative liabilities	824,763
TOTAL CURRENT LIABILITIES	$ 2,501,984	$ 1,531,814
LONG TERM LIABILITIES
Notes Payable		100,000
Notes Payable-Related Party		5,500
Accrued Interest		8,913
Accrued Interest on loan-related party		417
TOTAL LONG TERM LIABILITIES		114,930
TOTAL LIABILITIES	$ 2,501,984	1,646,644
STOCKHOLDERS' DEFICIT
Preferred stock (10,000,000 Shares Authorized; Par Value $.0001 5,000,000 and 5,000,000 shares issued and outstanding as at March 31, 2015 and March 31, 2014)	500	500
Common stock (500,000,000 Shares Authorized; No Par Value; 162,205,494 and 135,979,802 shares issued and outstanding as at March 31, 2015 and March 31, 2014)	2,072,814	1,029,161
Additional Paid-in Capital	8,150,332	6,429,500
Stock Subscription Payable	55,480	8,812
Accumulated Deficit	(12,415,279)	(9,091,287)
TOTAL STOCKHOLDERS' DEFICIT	(2,136,153)	(1,623,314)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 365,831	$ 23,330

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2015	Mar. 31, 2014
Stockholder Equity
Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	5,000,000	5,000,000
Preferred Stock, Shares Outstanding	5,000,000	5,000,000
Common Stock, Par Value	$ 0	$ 0
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares Issued	162,205,494	135,979,802
Common Stock, Shares Outstanding	162,205,494	135,979,802

STATEMENT OF OPERATIONS

STATEMENT OF OPERATIONS - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
REVENUES
Sales	$ 190	$ 1,270
OPERATING EXPENSES
Amortization and Depreciation	5,166	4,048
Advertisement and Promotion	18,900	19,953
General and Administrative	1,687,903	288,739
Professional Fees	88,580	84,066
TOTAL OPERATING EXPENSES	1,800,549	396,806
OPERATING LOSS	(1,800,549)	(395,536)
OTHER INCOME (EXPENSES)
Interest Expense	$ (193,314)	(68,799)
Interest Expense - Related Party		$ (69,015)
Derivative expense	$ (279,521)
Loss on derivative liabilities	(160,869)
Loss on extinguishment of debt	(714,711)
Amortization of debt discount	(166,568)
Amortization of debt offering costs	(14,543)
Debt Forgiveness	$ 5,893
Financing Cost		$ (6,250,000)
TOTAL OTHER EXPENSES	$ (1,523,633)	(6,387,813)
NET LOSS	$ (3,323,992)	$ (6,783,349)
Weighted average shares outstanding basic and diluted	133,601,913	135,920,110
Loss Per Share Basic and diluted	$ (0.02)	$ (0.05)

STATEMENTS OF STOCKHOLDERS' DEF

STATEMENTS OF STOCKHOLDERS' DEFICIT - 12 months ended Mar. 31, 2015 - USD ($)	Preferred Shares	Common Shares	Additional Paid-In Capital	Stock/Subscriptions Payable	Retained Earnings (Deficit)	Total
Beginning Balance, Shares at Mar. 31, 2014	5,000,000	135,979,802
Beginning Balance, Amount at Mar. 31, 2014	$ 500	$ 1,029,161	$ 6,429,500	$ 8,812	$ (9,091,287)	$ (1,623,314)
Shares issued for compensation, Shares		4,106,014
Shares issued for compensation, Amount		$ 378,386		$ 43,172		$ 421,558
Cancellation of shares, Shares		(9,600,000)
Cancellation of shares, Amount
Shares issued debt conversion, Shares		29,905,505
Shares issued debt conversion, Amount		$ 507,316				$ 507,316
Shares issued for cash, Shares		1,470,000
Shares issued for cash, Amount		$ 147,000				147,000
Shares issued for legal services, Shares		344,173
Shares issued for legal services, Amount		$ 10,951		$ 3,496		14,447
Compensation-warrants/options			$ 813,827			813,827
Derivative liabilities settled with issuance of common stock			$ 907,005			907,005
Net loss					$ (3,323,992)	(3,323,992)
Ending Balance, Shares at Mar. 31, 2015	5,000,000	162,205,494
Ending Balancre, Amount at Mar. 31, 2015	$ 500	$ 2,072,814	$ 8,150,332	$ 55,480	$ (12,415,279)	$ (2,136,153)

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (3,323,992)	$ (6,783,349)
Adjustments for non-cash items:
Amortization and Depreciation	$ 8,418	4,048
Preferred stock issued for financing cost		6,250,000
Stock issued for compensation	$ 421,558	$ 23,812
Stock issued for services	14,447
Loss on extingishment of debt	708,822
Loss on derivative liabilitiy	160,869
Intial devivative expense	279,521
Options issued for services	813,827
Amortization of debt discount	166,568
Changes in Operating Assets and Liabilities:
Prepaid expenses	(40,105)
Accounts payable and accrued liabilities	131,069	$ (1,883)
Accrued interest	87,366	68,798
Accrued interest on loan-related party	$ 73,779	69,015
Accounts payable-related party		8,700
NET CASH USED IN OPERATING ACTIVITIES	$ (497,853)	$ (360,859)
CASH FLOWS FROM INVESTING ACTIVITIES
Computer equipment	(3,680)
Software development costs	(60,362)
Note receivable	(59,204)
NET CASH USED IN INVESTING ACTIVITIES	(123,246)
CASH FLOWS FROM FINANCING ACTIVITIES
Common stock issuance	147,000
Proceeds from notes payable	85,000	$ 360,000
Proceeds from convertible debt	$ 576,667
Proceeds from loan-related party		$ 5,500
NET CASH PROVIDED BY FINANCING ACTIVITIES	$ 808,667	365,500
NET INCREASE IN CASH AND CASH EQUIVALENTS	187,568	4,641
CASH AND CASH EQUIVALENTS
Cash and Cash Equivalents Beginning of year	15,504	10,863
Cash and Cash Equivalents End of year	203,072	$ 15,504
Supplemental Disclosures Of Cash Flow Information:
Shares issued in settlement of interest on convertible debt	1,414,321
Original issue discounts	27,056
Original debt discount against derivative liabilities	576,667
Common Stock Issued to Satisfy Common Stock Payable	8,812	$ 14,625
Intial value of the derivative liabilities	$ 499,994

Nature of Operations

Nature of Operations	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Nature of Operations	Ecrypt Technologies Inc., a Colorado corporation ("the Company"), was incorporated on April 19, 2007. The Company's business operations are oriented around the marketing and distribution of proprietary and allied security, defense and information security software, hardware and services. Products include software, hardware and services, and span a diverse variety of industries including, but not limited to, email security, user authentication, robotics, and cyber breach protection.

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Significant Accounting Policies	Basis of Presentation The financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles of the United States of America ("US GAAP"). Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions impact both assets and liabilities, including but not limited to: net realizable value of accounts receivable, estimated useful lives and potential impairment of property and equipment, the valuation of intangible assets, estimate of fair value of share based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount, estimates of tax liabilities and estimates of the probability and potential magnitude of contingent liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future non-conforming events. Accordingly, actual results could differ significantly from estimates. Fiscal Year The Company's fiscal year-end is March 31. Cash and Cash Equivalents Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less. The Company had no cash equivalents. Property and Equipment Property and equipment is stated at cost, less accumulated depreciation and is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful lives, ranging from 5-7 years of the respective assets. Expenditures for maintenance and repairs are charged to expense as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations. Long-Lived Assets The Company reviews long-lived assets and certain identifiable intangibles held and used for possible impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In evaluating the fair value and future benefits of its intangible assets, management performs an analysis of the anticipated undiscounted future net cash flow of the individual assets over the remaining amortization period. The Company recognizes an impairment loss if the carrying value of the asset exceeds the expected future cash flows. Income Taxes The Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes, as clarified by ASC 740-10, Accounting for Uncertainty in Income Taxes. Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which the Company operates, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the "more likely than not" criteria of ASC 740. ASC 740-10 requires that the Company recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the "more-likely-than-not" threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority. Uncertainty as a Going Concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has suffered recurring losses from operations since inception (April 19, 2007) up to March 31, 2015 of $12,415,279 which raises substantial doubt about its ability to continue as a going concern. The Company's ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through a private placement and public offering of its common stock. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company's ability to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty. Fair Value of Financial Instruments The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: · Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities. · Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. · Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments. The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 3. Embedded Conversion Features The Company evaluates embedded conversion features within convertible debt under ASC 815 "Derivatives and Hedging" to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 "Debt with Conversion and Other Options" for consideration of any beneficial conversion feature. Derivative Financial Instruments The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. Beneficial Conversion Feature For conventional convertible debt where the rate of conversion is below market value, the Company records a "beneficial conversion feature" ("BCF") and related debt discount. When the Company records a BCF, the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument (offset to additional paid in capital) and amortized to interest expense over the life of the debt. Debt Issue Costs and Debt Discount The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed. Original Issue Discount For certain convertible debt issued, the Company may provide the debt holder with an original issue discount. The original issue discount would be recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt. Extinguishments of Liabilities The Company accounts for extinguishments of liabilities in accordance with ASC 860-10 (formerly SFAS 140) "Accounting for Transfers and Servicing of Financial Assets and Extinguishment of Liabilities". When the conditions are met for extinguishment accounting, the liabilities are derecognized and the gain or loss on the sale is recognized. Revenue Recognition Product revenue and miscellaneous income are recognized as earned. The Company recognizes revenue and gains when earned and related costs of sales and expenses when incurred. The Company recognizes revenue in accordance with Accounting Standards Codification Section 605-10-599, Revenue Recognition, Overall, SEC Materials ("Section 605-10-599"). Section 605-10-599 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services rendered; (3) the fee is fixed and determinable; and (4) collectability is reasonably assured. Cost of products sold consists of the cost of the purchased goods and labor related to the corresponding sales transaction. When a right of return exists, the Company defers revenues until the right of return expires. The Company recognizes revenue from services at the time the services are completed. Stock-Based Compensation - Employees The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. The fair value of share options and similar instruments is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as follows: · Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding. Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees' expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments. Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the simplified method, i.e., expected term = ((vesting term + original contractual term) / 2), if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the actual method to calculate expected term of share options and similar instruments as the company does have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. · Expected volatility of the entity's shares and the method used to estimate it. Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses its actual historical volatility over the expected contractual life of the share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market. · Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments. We expect and use zero rate. · Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments. Generally, all forms of share-based payments, including stock option grants, warrants and restricted stock grants and stock appreciation rights are measured at their fair value on the awards' grant date, based on estimated number of awards that are ultimately expected to vest. The expense resulting from share-based payments is recorded in general and administrative expense in the statements of operations. Stock-Based Compensation - Non Employees Equity Instruments Issued to Parties Other Than Employees for Acquiring Goods or Services The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Sub-topic 505-50 of the FASB Accounting Standards Codification ("Sub-topic 505-50"). Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. The fair value of share options and similar instruments is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as follows: · Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder's expected exercise behavior into the fair value (or calculated value) of the instruments. The Company uses historical data to estimate holder's expected exercise behavior. · Expected volatility of the entity's shares and the method used to estimate it. Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses its actual historical volatility over the expected contractual life of the share options or similar instruments as its expected volatility. · Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments. We expect and use zero rate. · Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments. Pursuant to ASC paragraph 505-50-25-7, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic. Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9, an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a share option and similar instrument that the counterparty has the right to exercise expires unexercised. Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded. Related Parties The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. Foreign Currency Translation The measurement currency of the Company is the U.S. dollar. Transactions in foreign currencies are translated at the exchange rate in effect at the transaction date. Monetary assets and liabilities denominated in other than the measurement currency are translated at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in earnings. Net Earnings (Loss) per Share Basic and diluted net loss per share information is presented under the requirements of ASC Topic 260, Earnings per Share. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, less shares subject to repurchase. Diluted net loss per share reflects the potential dilution of securities by adding other common stock equivalents, including stock options, shares subject to repurchase, warrants and convertible notes in the weighted-average number of common shares outstanding for a period, if dilutive.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Recent Accounting Pronouncements	In April 2014, the FASB issued ASU No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. The amendments in this Update change the requirements for reporting discontinued operations in Subtopic 205-20. Under the new guidance, a discontinued operation is defined as a disposal of a component or group of components that is disposed of or is classified as held for sale and "represents a strategic shift that has (or will have) a major effect on an entity's operations and financial results." The ASU states that a strategic shift could include a disposal of (i) a major geographical area of operations, (ii) a major line of business, (iii) a major equity method investment, or (iv) other major parts of an entity. Although "major" is not defined, the standard provides examples of when a disposal qualifies as a discontinued operation. The ASU also requires additional disclosures about discontinued operations that will provide more information about the assets, liabilities, income and expenses of discontinued operations. In addition, the ASU requires disclosure of the pre-tax profit or loss attributable to a disposal of an individually significant component of an entity that does not qualify for discontinued operations presentation in the financial statements. The ASU is effective for public business entities for annual periods beginning on or after December 15, 2014, and interim periods within those years. In May 2014, the FASB has issued ASU No. 2014-09, "Revenue from Contracts with Customers (Topic 606)". The guidance in this update supersedes the revenue recognition requirements in Topic 605, "Revenue Recognition." In addition, the existing requirements for the recognition of a gain or loss on the transfer of nonfinancial assets that are not in a contract with a customer (for example, assets within the scope of Topic 360, Property, Plant, and Equipment, and intangible assets within the scope of Topic 350, Intangibles-Goodwill and Other) are amended to be consistent with the guidance on recognition and measurement (including the constraint on revenue) in this Update. Under the new guidance, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The amendments in ASU No, 2014-09 are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted. We do not believe the adoption of this update will have a material impact on our financial statements. Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

Stockholders' Deficit

Stockholders' Deficit	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Stockholders' Deficit	a) Authorized: 500,000,000 Common shares with no par value; 162,205,494 Common shares issued and outstanding; 10,000,000 Preferred shares with $0.0001 par value; 5,000,000 Preferred shares issued and outstanding: During the year ended March 31, 2015, the Company effected the following stock transactions: During the year ended March 31, 2015, the company cancelled 9,600,000 shares of common stock. During the year ended March 31, 2015, the company issued 29,905,505 shares of common stock for debt conversions with a value of $507,316. During the year ended March 31, 2015 the company issued 4,106,014 shares of common stock for compensation valued at $421,558. The per share price of the shares ranged from $0.03 to $0.19. During the year ended March 31, 2015, the Company entered into private placement subscription agreements that offered a total of 1,470,000 units for a value of $147,000, or $0.10 per unit. Each unit consists of one (1) share of the Company's common stock, and one-half (1/2) common stock purchase Warrant. One full warrant entitles the holder to purchase one (1) share of the Corporation's common stock at a price of $0.15 per share at any time within a 12 month period from the date of closing. During the year ended March 31, 2015, the Company issued 344,173 shares of common stock in exchange for legal services valued at $14,447.

Stock Options and Warrants

Stock Options and Warrants	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Stock Options and Warrants	On February 16, 2012 the Company granted a non-qualified stock option to its director as compensation for his services. The director is entitled to purchase a total of three hundred thousand (300,000) shares of restricted common stock for a price equal to $0.30 per share (Exercise Price), exercisable over a ten-year period thereafter. The option shall be vested during the 12 month period. As to the total number of Shares with respect to which the Option is granted, the Option shall be exercisable as follows: (i) 25% of the Option in the aggregate may be exercised upon the mutual execution of this Agreement (ii) 50% of the Option in the aggregate may be exercised on or after the four month anniversary of the Grant Date; (iii) 75% of the Option in the aggregate may be exercised on or after the eight month anniversary of the Grant Date; and (iv) 100% of the Option in the aggregate may be exercised on or after the twelve month anniversary of the Grant Date (the twelve month period commencing on the Grant Date and ending on the twelve month anniversary of the Grant Date being referred to as the "Vesting Period"). As of March 31, 2015, the director has not exercised any rights. The total fair value of these options at the date of grant was estimated to be $180,000 and was determined using the Black-Scholes option pricing model with an expected life of 10 years, a risk free interest rate of 1.99%, a dividend yield of 0% and expected volatility of 419%. This $180,000 was recorded as stock based compensation expense through March 31, 2014 based on three hundred thousand (300,000) options vested. Number of Options Weighted-Average Exercise Price Weighted- Average Remaining Outstanding at as at 3/31/2014 300,000 $ 0.30 9.88 Granted - $ - - Exercised - $ NA NA Cancelled - $ NA NA Outstanding as at 3/31/2015 300,000 $ 0.30 8.88 Exercisable at 3/31/2015 300,000 $ 0.30 On March 27, 2015 the Company granted a non-qualified cashless stock warrant to its officer as compensation for his services. The officer is entitled to purchase a total of thirty million (30,000,000) shares of restricted common stock for a price equal to $0.03 per share (Exercise Price), exercisable over a five-year period thereafter. As of March 31, 2015, the officer has not exercised any rights. The total fair value of these options at the date of grant was estimated to be $813,827 and was determined using the Black-Scholes option pricing model with an expected life of 5 years, a risk free interest rate of 1.42%, a dividend yield of 0% and expected volatility of 207.12%. $813,827 was recorded as stock based compensation expense through March 31, 2015 based on a total of thirty million (30,000,000) shares vested. Number of warrants Weighted-Average Exercise Price Weighted- Average Remaining Outstanding at as at 3/31/2014 -0- $ -0- -0- Granted 30,000,000 $ .03 5.0 Exercised - $ NA NA Cancelled - $ NA NA Outstanding as at 3/31/2015 30,000,000 $ 0.03 5.0 Exercisable at 3/31/2015 30,000,000 $ 0.03 During the year ended March 31, 2015, the Company entered into a private placement subscription agreement that offers a total of 1,470,000 units for a value of $147,000, or $0.10 per unit. Each unit consists of one (1) share of the Company's common stock, and one-half (1/2) common stock purchase Warrant. One full warrant entitles the holder to purchase one (1) share of the Corporation's common stock at a price of $0.15 per share at any time within a 12 month period from the date of closing from July 2015. As of March 31, 2015, the warrant holders have not exercised any rights. The total fair value of these options at the date of grant was estimated to be $89,432 and was determined using the Black-Scholes option pricing model with an expected life of 1 year, a risk free interest rate of .25%, a dividend yield of 0% and expected volatility in a range of 185.10% to 207.49%. $89,432 was not recorded as expense through March 31, 2015 since the warrants were issued in a private placement in exchange for cash. Number of warrants Weighted-Average Exercise Price Weighted- Average Remaining Outstanding at as at 3/31/2014 -0- $ -0- -0- Granted 735,000 $ .15 .5 Exercised - $ NA NA Cancelled - $ NA NA Outstanding as at 3/31/2015 735,000 $ 0.15 .5 Exercisable at 3/31/2015 735,000 $ 0.15 In conjunction with the convertible note issued by the Company and the three promissory notes issued to the Company for the three additional tranches of funding to the Company, the Company issued four warrants for a total number of shares equal to $123,750 ($41,250 for the first warrant corresponding to funding on February 6, 2015, and $27,500 for the other three warrants corresponding to the future tranches of funding to the Company) divided by the conversion market price in the convertible note. The warrants have an exercise price of $0.10, subject to adjustment, and expire on January 3, 2020. Each of the warrants are only exercisable after the corresponding tranche of funding to the Company has been paid. Therefore, the first warrant is currently exercisable, but the other three warrants are not. The total fair value of these warrants at the date of grant was estimated to be $41,250 and was determined using the Black-Scholes option pricing model with an expected life of 5 years, a risk free interest rate of 1.28%, a dividend yield of 0% and expected volatility of 191.21%. $41,250 was recorded as derivative expense as of the date of issuance and as of March 31, 2015 a derivative liability of $23,925 is reflected on the balance sheet. Number of warrants Weighted-Average Exercise Price Weighted- Average Remaining Outstanding at as at 3/31/2014 -0- $ -0- -0- Granted 916,667 $ .10 5.0 Exercised - $ NA NA Cancelled - $ NA NA Outstanding as at 3/31/2015 916,667 $ 0.10 5.0 Exercisable at 3/31/2015 916,667 $ 0.10

Loan-Related Party

Loan-Related Party	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Loan-Related Party	As of March 31, 2015 and March 31, 2014, the balance of loans due to a related party was $558,500 and $553,000, respectively. The Company issued on May 18, 2010 a $215,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement. The Company issued on April 29, 2011 a $15,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement. The Company issued on May 9, 2011 a $36,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement. The Company issued on June 24, 2011 a $100,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement. The Company issued on July 7, 2011 a $40,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement. The Company issued on August 5, 2011 a $24,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement. The Company issued on September 2, 2011 a $20,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement. The Company issued on September 30, 2011 a $20,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement. The Company issued on October 19, 2011 a $25,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement. The Company issued on December 6, 2011 a $20,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement. The Company issued on January 11, 2012 a $38,000 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and matured on November 30, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement. The Company issued on June 27, 2013 a $5,500 unsecured note payable to a shareholder. The note bears interest at 10%, compounded annually and will mature on June 27, 2015. Interest expense for the years ended March 31, 2015, and 2014, was $193,313 and $35,351 respectively.

Note Payable

Note Payable	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Notes Payable	As of March 31, 2015 and March 31, 2014, the balance of loans due to third parties was $430,788 and $759,854, respectively. During the year ended March 31, 2015 The loan balance was reduced by the issuance of convertible debt of $500,000 and the forgiveness of debt and interest payable of $5,893. The Company issued on December 18, 2012 a $49,980 unsecured note payable to a third party. The note bears interest at 10%, compounded annually and matured on December 18, 2014. On February 16, 2015 the Company secured a note payable extension through April 1, 2015 with no change in original terms of the agreement.

Convertible Debt and Derivative

Convertible Debt and Derivative liabilities	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Convertible Debt and Derivative liabilities	The Company has received subscriptions receivable totaling $300,000 through the issuances of two 8% convertible promissory notes The outstanding balance of these notes are convertible into a variable number of the Company's common stock. Based on a conversion ratio of 68% of the lowest closing bid prices for 20 days prior to conversion The outstanding balance of this note is convertible into a variable number of the Company's common stock. Therefore the Company accounted for these Notes under ASC Topic 815-15 "Embedded Derivative." The derivative component of the obligation are initially valued and classified as a derivative liability with an offset to discounts on convertible debt. Discounts have being amortized to interest expense over the respective term of the related note. The balance of the convertible note at March 31, 2015 net of the discount and net of the receivable amounted to $-0- A recap of the balance of outstanding convertible debt is as follows: Principal balance $ 300,000 Receivable-reflected in equity (300,000 ) Balance maturing for the period ending: March 31, 2015 $ -0- The Company has extinguished debt totaling $500,000 through the issuances of two 8% and one 10% convertible promissory notes. The outstanding balances of these notes are convertible into a variable number of the Company's common stock. Based on a conversion ratio of 68% of the lowest closing bid prices for 20 days prior to conversion Therefore the Company accounted for these Notes under ASC Topic 815-15 "Embedded Derivative." The derivative component of the obligation are initially valued and classified as a derivative liability with an offset to discounts on convertible debt. Discounts have being amortized to interest expense over the respective term of the related note. Amortization of the discounts for the year ended March 31, 2015 totaled $166,568, which was charged to expense. The Company valued the derivative liabilities at March 31, 2015 at $824,763. The Company used the Black Scholes Option Model with a risk-free interest rates from .014% to .56%, volatility from 187.69 to 324.12%%, trading prices from $.014 to $.149 per share and conversion prices from $.002 to $.149 per share. On January 11, 2015, the Company entered into a securities purchase agreement providing for the purchase of two convertible promissory notes in the aggregate principal amount of $52,000 each. One of the notes was funded on January 13, 2015, with the Company receiving $47,500 of net proceeds after payment of legal and origination expenses. The note bears interest at the rate of 8% per annum, is due and payable on January 9, 2015, and may be converted at any time after funding into shares of Company common stock at a conversion price equal to 67% of the lowest closing bid price on the OTCQB during the 15 prior trading days. The second note, which has not been funded, has the same interest and conversion terms as the first note, but may be offset by a secured promissory note issued to the Company for $50,000, due on September 9, 2015, and accruing interest at the rate of 8% per annum. On January 19, 2015, the Company issued a convertible promissory note in the face amount of $100,000, which bears interest at the rate of 12% per annum, is due and payable on July 16, 2015, and may be converted at any time after funding into shares of Company common stock at a conversion price equal to the lesser of (a) 55% of the lowest trading price during the 20 days preceding the execution of the note, or (b) 55% of the of the lowest traded price during the 20 trading days preceding conversion. The note was funded on January 28, 2015, with the Company receiving $93,000 of net proceeds after payment of legal and origination expenses. On January 21, 2015, the Company issued a convertible promissory note in the face amount of $400,000, of which the Company is to assume $40,000 in original interest discount ("OID"), which together with any unpaid accrued interest is due two years after any funding of the note. The note is to be funded at the note holders discretion, and the initial tranche was funded on January 21, 2015, when the Company received cash in the amount of $50,000. The note is pre-payable for 90 days without interest, and incurs a one-time interest charge of 12% thereafter. The note balance funded (plus a pro rata portion of the OID together with any unpaid accrued interest) is convertible into shares of Company common stock at a conversion price equal to the lesser of $0.08 or 60% of the lowest traded price during the 25 prior trading days. On February 3, 2015, the Company issued a collateralized secured convertible promissory for a 10% convertible promissory note with an aggregate principal amount of $252,500, of which the company is to assume an original issue discount of $22,500 (the "OID") and legal fees and other expenses totaling $5,000, which together with any unpaid accrued interest is due on November 3, 2015. The note is to be issued in tranches with an initial tranche of $87,500, of which the company received $75,000 on February 6, 2015, with the remaining $5,000 being used for legal and other expenses and the Company assuming $7,500 of the OID. This convertible note together with any unpaid accrued interest is convertible into shares of Company common stock at a conversion price equal to the 60% of the average of the lowest three closing bid prices during the 20 prior trading days. The remaining three tranches, which have not yet been funded, of $55,000 under the note will consist of $50,000 in principal and $5,000 of the OID, and may be offset by three $50,000 promissory notes issued in favor of the Company, accruing interest at 8% per annum and maturing on November 3, 2015. In conjunction with the convertible note issued by the Company and the three promissory notes issued to the Company for the three additional tranches of funding to the Company, the Company issued four warrants for a total number of shares equal to $123,750 ($41,250 for the first warrant corresponding to funding on February 6, 2015, and $27,500 for the other three warrants corresponding to the future tranches of funding to the Company) divided by the conversion market price in the convertible note. The warrants have an exercise price of $0.10, subject to adjustment, and expire on January 3, 2020. Each of the warrants is only exercisable after the corresponding tranche of funding to the Company has been paid. Therefore, the first warrant is currently exercisable, but the other three warrants are not. On February 10, 2015, the Company entered into an equity purchase agreement with a third party investor dated February 6, 2015, whereby the third party agreed to purchase up to $1,800,000 of the Company's common stock, to be registered in a Form S-1 registration statement. The agreement will have a one-year term unless sooner terminated because $1,800,000 of the Company's common stock has already been sold to the investor. During the term, the Company will have the right to deliver up to two put notices per month requiring it to purchase up to a maximum of $75,000 of shares for a specific amount. The purchase price for the shares covered by the put notice shall be equal to 75% of the lowest closing bid price for the ten trading days immediately preceding clearing of the estimated put shares (defined below). The Company will deliver to the investor, simultaneously with delivery of a put notice, a number of shares equal to 120% of the investment amount divided by the closing price of the Company's common stock on the day preceding the put notice date. The actual number of shares purchased by the investor for the investment amount shall then be calculated by dividing the investment amount by the put purchase price. Any excess estimated put shares shall then be returned to the Company. The number of Shares sold to the investor at any time shall not exceed the number of such shares that, when aggregated with all other shares of common stock of the Company then beneficially owned by the investor, would result in the investor owning more than 9.99% of all of the Company's common stock then outstanding. Finally, as part of the equity purchase agreement, the investor is prohibited from executing any short sales of the Company's common stock during the term of the equity purchase agreement.

Fair Value Measurement

Fair Value Measurement	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Fair Value Measurement	The company uses the Black-Sholes model to calculate the fair value of the derivative liability. Our financial assets and (liabilities) carried at fair value measured on a recurring basis as of March 31, 2014 and 2015 consisted of the following: Fair Value Measurements Using Description Total Fair Value at March 31, 2015 Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Derivative liability $ 824,763 $ - $ 824,763 $ - Fair Value Measurements Using Description Total Fair Value at March 31, 2014 Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Derivative liability $ - $ - $ - $ -

Income Taxes

Income Taxes	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Income Taxes	The Company has a deferred tax asset as shown in the following: 2015 2014 Deferred tax asset: Tax loss carryforward $ 3,163,345 $ 2,987,956 Valuation allowance (3,163,345 ) (2,987,956 ) Net deferred tax asset $ 0 $ 0 A valuation allowance has been recognized to offset the deferred tax assets because realization of such assets is uncertain. The income tax provision differs from the amount of income tax determined by applying the U.S. federal and state income statutory tax rates to pretax income (loss) from continuing operations as follows: 2015 2014 Tax benefit at statutory rates $ 260,759 $ 2,373,407 Change in valuation allowance $ (260,759 ) $ (2,373,407 ) Net provision for income taxes $ 0 $ 0 The Company has net operating loss carry-forwards of approximately $9,304,000 at March 31, 2015 that expire beginning in 2025. However, utilization of these losses may be limited pursuant to Section 382 of the Internal Revenue Code due to a recapitalization and subsequent stock issuances.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Deferred Revenue, Commitments, and Contingencies	None

Earnings Per Share - Potential

Earnings Per Share - Potential Dilutive Securities	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Earnings Per Share - Potential Dilutive Securities	Basic earnings per share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the weighted average number of common and potentially dilutive securities outstanding during the period. Potentially dilutive securities consist of the incremental common shares issuable upon on exercise of stock options and warrants (using the treasury stock method). Potentially dilutive securities are excluded from the computation if their effect is anti-dilutive. The Company had 34,291,724 and 0 in potentially as March 31, 2015 and 2014, respectively.

Subsequent Events

Subsequent Events	12 Months Ended
	Mar. 31, 2015
Notes to Financial Statements
Subsequent Events	On April 10, 2015, the Company issued a convertible promissory note in the face amount of $105,000, which bears interest at the rate of 10% per annum, is due and payable on April 10, 2016, and may be converted at any time after funding into shares of Company common stock at a conversion price equal to the lesser of (a) 60% of the lowest trading price during the 20 days preceding the execution of the note, or (b) 60% of the of the lowest traded price during the 3 trading days preceding conversion. The note was funded on April 10, 2015. On February 10, 2015, the Company entered into an engagement for legal representation, whereby the Company agreed for compensation to consist of $1,000 in cash and the issuance of shares of the Company's stock equal to $3,000 divided by the lowest traded price of the Client's common stock during the previous month. From April 1, 2015 through June 13, 2015, the Company issued a total of 470,881 shares of common stock for a value of $12,000. On June 2, 2015, the Company entered into Asset Purchase Agreement with Dependable Critical Infrastructure, Inc. f/k/a DTREDS Consolidated Inc., a Delaware corporation ("DCI"), and Viking Telecom Services, LLC, a Minnesota limited liability company ("Viking"). Pursuant to the Agreement, the parties agreed that the Company would purchase assets of DCI relating to Viking which DCI had acquired from Viking (general intangibles, including contract rights, office furniture, IBM server, 2011 Chevrolet Silverado 2500 Diesel truck, and accounts receivable after January 1, 2015), in consideration of the Company (1) assuming limited liabilities associated with Viking (loan payment for Chevrolet truck in the amount of $668 per month, loan payment to Joshua Claybaugh of $5,000 per month 11 months), (2) issuing the owners of DCI a total of 62,236,075 shares of Company common stock, and (3) paying DCI $200,000 as soon as reasonably possible after closing of the acquisition. The Company's CEO, Dr. Cellucci, is the CEO and Chairman of DCI, and a minority owner of DCI. On July 9, 2015 the Company issued a total of 30,184,528 shares of common stock and 264,503 shares of Series B preferred stock under this agreement. On June 14, 2015, Company entered into a Settlement Agreement and Partial Waiver and Release On December 19, 2014, the Company issued a convertible back end note, with a face value of $156,000 and stated interest of 8% to a third party investor. The note is convertible at any time following the funding of the note, convertible into a variable number of the Company's common stock, based on a conversion ratio of 68% of the lowest closing bid prices for 20 days prior to conversion. The note was funded on June 18, 2015. On December 19, 2014, the Company issued a convertible back end note, with a face value of $156,000 and stated interest of 8% to a third party investor. The note is convertible at any time following the funding of the note, convertible into a variable number of the Company's common stock, based on a conversion ratio of 68% of the lowest closing bid prices for 20 days prior to conversion. The note was funded on June 18, 2015. On December 19, 2014, the Company issued a convertible note payable, with a face value of $156,000 and stated interest of 8% to a third party investor. The outstanding balance of this note is convertible into a variable number of the Company's common stock, based on a conversion ratio of 67% of the lowest closing bid prices for 20 days prior to conversion. On June 30, 2015, the investor converted a total of $31,500 of the face value and $1,874.47 of accrued interest, into 6,668,226 shares of common stock. On July 20, 2015, the Company entered into a Settlement Agreement(the "Micro-Tech Settlement Agreement") with Micro-Tech Industries, Ltd., lender and preferred shareholder of the Company ("Micro-Tech"). Micro-Tech owns 839,500 shares of the Company's 2,622,500 issued and outstanding shares of Series A Convertible Preferred Stock (the "Micro-Tech Preferred Stock"). Pursuant to the Micro-Tech Settlement Agreement, Micro-Tech agreed to immediately return all of the Micro-Tech Preferred Stock to the Company for cancellation in consideration for the Company issuing 7,975,250 shares of common stock to Micro-Tech. As of July 31, 2015, the 839,500 preferred shares had not been cancelled and the common shares not issued. On July 20, 2015, the Company entered into a Settlement Agreement (the "Whonon Settlement Agreement") with Whonon Trading S. A., lender and preferred shareholder of the Company ("Whonon"). Whonon owns 1,783,000 shares of the Company's 2,622,500 issued and outstanding shares of Series A Convertible Preferred Stock (the "Whonon Preferred Stock"). Pursuant to the Whonon Settlement Agreement, Whonon agreed to immediately return all of the Whonon Preferred Stock to the Company for cancellation in consideration for the Company issuing 16,938,500 shares of common stock to Whonon. As of July 31, 2015, the preferred shares had not been cancelled and the common shares not issued. On July 20, 2015, the Company's Officer returned 22,376,836 shares of common stock to the Company for cancellation in exchange for the issuance of 223,768 shares of Series C Preferred Stock. On July 20, 2015, a related party shareholder returned 9,600,000 shares of common stock to the Company for cancellation in exchange for the issuance of 96,000 shares of Series C Preferred Stock.

Significant Accounting Polici20

Significant Accounting Policies (Policies)	12 Months Ended
	Mar. 31, 2015
Significant Accounting Policies Policies
Basis of Presentation	The financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles of the United States of America ("US GAAP").
Use of Estimates	The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions impact both assets and liabilities, including but not limited to: net realizable value of accounts receivable, estimated useful lives and potential impairment of property and equipment, the valuation of intangible assets, estimate of fair value of share based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount, estimates of tax liabilities and estimates of the probability and potential magnitude of contingent liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future non-conforming events. Accordingly, actual results could differ significantly from estimates.
Fiscal Year	The Company's fiscal year-end is March 31.
Cash and Cash Equivalents	Cash and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less. The Company had no cash equivalents.
Property and Equipment	Property and equipment is stated at cost, less accumulated depreciation and is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful lives, ranging from 5-7 years of the respective assets. Expenditures for maintenance and repairs are charged to expense as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the statements of operations.
Long-Lived Assets	The Company reviews long-lived assets and certain identifiable intangibles held and used for possible impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. In evaluating the fair value and future benefits of its intangible assets, management performs an analysis of the anticipated undiscounted future net cash flow of the individual assets over the remaining amortization period. The Company recognizes an impairment loss if the carrying value of the asset exceeds the expected future cash flows.
Income Taxes	The Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes, as clarified by ASC 740-10, Accounting for Uncertainty in Income Taxes. Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws. Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year. In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which the Company operates, estimates of future taxable income, and available tax planning strategies. If tax regulations, operating results or the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required. Valuation allowances are recorded related to deferred tax assets based on the "more likely than not" criteria of ASC 740. ASC 740-10 requires that the Company recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the "more-likely-than-not" threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.
Uncertainty as a Going Concern	The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has suffered recurring losses from operations since inception (April 19, 2007) up to March 31, 2015 of $12,415,279 which raises substantial doubt about its ability to continue as a going concern. The Company's ability to continue as a going concern is dependent upon its ability to generate profitable operations in the future and/or obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management has plans to seek additional capital through a private placement and public offering of its common stock. These plans, if successful, will mitigate the factors which raise substantial doubt about the Company's ability to continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.
Fair Value of Financial Instruments	The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: · Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities. · Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. · Level 3 - Unobservable inputs reflecting the Company's assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. The carrying amounts of the Company's financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable & accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments. The Company accounts for its derivative liabilities, at fair value, on a recurring basis under level 3.
Embedded Conversion Features	The Company evaluates embedded conversion features within convertible debt under ASC 815 "Derivatives and Hedging" to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 "Debt with Conversion and Other Options" for consideration of any beneficial conversion feature.
Derivative Financial Instruments	The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of it financial instruments, including stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported as charges or credits to income. For option-based simple derivative financial instruments, the Company uses the Black-Scholes option-pricing model to value the derivative instruments at inception and subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
Beneficial Conversion Feature	For conventional convertible debt where the rate of conversion is below market value, the Company records a "beneficial conversion feature" ("BCF") and related debt discount. When the Company records a BCF, the relative fair value of the BCF is recorded as a debt discount against the face amount of the respective debt instrument (offset to additional paid in capital) and amortized to interest expense over the life of the debt.
Debt Issue Costs and Debt Discount	The Company may record debt issue costs and/or debt discounts in connection with raising funds through the issuance of debt. These costs may be paid in the form of cash, or equity (such as warrants). These costs are amortized to interest expense over the life of the debt. If a conversion of the underlying debt occurs, a proportionate share of the unamortized amounts is immediately expensed.
Original Issue Discount	For certain convertible debt issued, the Company may provide the debt holder with an original issue discount. The original issue discount would be recorded to debt discount, reducing the face amount of the note and is amortized to interest expense over the life of the debt.
Extinguishments of Liabilities	The Company accounts for extinguishments of liabilities in accordance with ASC 860-10 (formerly SFAS 140) "Accounting for Transfers and Servicing of Financial Assets and Extinguishment of Liabilities". When the conditions are met for extinguishment accounting, the liabilities are derecognized and the gain or loss on the sale is recognized.
Revenue Recognition	Product revenue and miscellaneous income are recognized as earned. The Company recognizes revenue and gains when earned and related costs of sales and expenses when incurred. The Company recognizes revenue in accordance with Accounting Standards Codification Section 605-10-599, Revenue Recognition, Overall, SEC Materials ("Section 605-10-599"). Section 605-10-599 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services rendered; (3) the fee is fixed and determinable; and (4) collectability is reasonably assured. Cost of products sold consists of the cost of the purchased goods and labor related to the corresponding sales transaction. When a right of return exists, the Company defers revenues until the right of return expires. The Company recognizes revenue from services at the time the services are completed.
Stock-Based Compensation - Employees	The Company accounts for its stock based compensation in which the Company obtains employee services in share-based payment transactions under the recognition and measurement principles of the fair value recognition provisions of section 718-10-30 of the FASB Accounting Standards Codification. Pursuant to paragraph 718-10-30-6 of the FASB Accounting Standards Codification, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. The fair value of share options and similar instruments is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as follows: · Expected term of share options and similar instruments: The expected life of options and similar instruments represents the period of time the option and/or warrant are expected to be outstanding. Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and employees' expected exercise and post-vesting employment termination behavior into the fair value (or calculated value) of the instruments. Pursuant to paragraph 718-10-S99-1, it may be appropriate to use the simplified method, i.e., expected term = ((vesting term + original contractual term) / 2), if (i) A company does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term due to the limited period of time its equity shares have been publicly traded; (ii) A company significantly changes the terms of its share option grants or the types of employees that receive share option grants such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term; or (iii) A company has or expects to have significant structural changes in its business such that its historical exercise data may no longer provide a reasonable basis upon which to estimate expected term. The Company uses the actual method to calculate expected term of share options and similar instruments as the company does have sufficient historical exercise data to provide a reasonable basis upon which to estimate expected term. · Expected volatility of the entity's shares and the method used to estimate it. Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses its actual historical volatility over the expected contractual life of the share options or similar instruments as its expected volatility. If shares of a company are thinly traded the use of weekly or monthly price observations would generally be more appropriate than the use of daily price observations as the volatility calculation using daily observations for such shares could be artificially inflated due to a larger spread between the bid and asked quotes and lack of consistent trading in the market. · Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments. We expect and use zero rate. · Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments. Generally, all forms of share-based payments, including stock option grants, warrants and restricted stock grants and stock appreciation rights are measured at their fair value on the awards' grant date, based on estimated number of awards that are ultimately expected to vest. The expense resulting from share-based payments is recorded in general and administrative expense in the statements of operations.
Stock-Based Compensation - Non Employees	Equity Instruments Issued to Parties Other Than Employees for Acquiring Goods or Services The Company accounts for equity instruments issued to parties other than employees for acquiring goods or services under guidance of Sub-topic 505-50 of the FASB Accounting Standards Codification ("Sub-topic 505-50"). Pursuant to ASC Section 505-50-30, all transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. The fair value of share options and similar instruments is estimated on the date of grant using a Black-Scholes option-pricing valuation model. The ranges of assumptions for inputs are as follows: · Expected term of share options and similar instruments: Pursuant to Paragraph 718-10-50-2(f)(2)(i) of the FASB Accounting Standards Codification the expected term of share options and similar instruments represents the period of time the options and similar instruments are expected to be outstanding taking into consideration of the contractual term of the instruments and holder's expected exercise behavior into the fair value (or calculated value) of the instruments. The Company uses historical data to estimate holder's expected exercise behavior. · Expected volatility of the entity's shares and the method used to estimate it. Pursuant to ASC Paragraph 718-10-50-2(f)(2)(ii) a thinly-traded or nonpublic entity that uses the calculated value method shall disclose the reasons why it is not practicable for the Company to estimate the expected volatility of its share price, the appropriate industry sector index that it has selected, the reasons for selecting that particular index, and how it has calculated historical volatility using that index. The Company uses its actual historical volatility over the expected contractual life of the share options or similar instruments as its expected volatility. · Expected annual rate of quarterly dividends. An entity that uses a method that employs different dividend rates during the contractual term shall disclose the range of expected dividends used and the weighted-average expected dividends. The expected dividend yield is based on the Company's current dividend yield as the best estimate of projected dividend yield for periods within the expected term of the share options and similar instruments. We expect and use zero rate. · Risk-free rate(s). An entity that uses a method that employs different risk-free rates shall disclose the range of risk-free rates used. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the expected term of the share options and similar instruments. Pursuant to ASC paragraph 505-50-25-7, if fully vested, non-forfeitable equity instruments are issued at the date the grantor and grantee enter into an agreement for goods or services (no specific performance is required by the grantee to retain those equity instruments), then, because of the elimination of any obligation on the part of the counterparty to earn the equity instruments, a measurement date has been reached. A grantor shall recognize the equity instruments when they are issued (in most cases, when the agreement is entered into). Whether the corresponding cost is an immediate expense or a prepaid asset (or whether the debit should be characterized as contra-equity under the requirements of paragraph 505-50-45-1) depends on the specific facts and circumstances. Pursuant to ASC paragraph 505-50-45-1, a grantor may conclude that an asset (other than a note or a receivable) has been received in return for fully vested, non-forfeitable equity instruments that are issued at the date the grantor and grantee enter into an agreement for goods or services (and no specific performance is required by the grantee in order to retain those equity instruments). Such an asset shall not be displayed as contra-equity by the grantor of the equity instruments. The transferability (or lack thereof) of the equity instruments shall not affect the balance sheet display of the asset. This guidance is limited to transactions in which equity instruments are transferred to other than employees in exchange for goods or services. Section 505-50-30 provides guidance on the determination of the measurement date for transactions that are within the scope of this Subtopic. Pursuant to Paragraphs 505-50-25-8 and 505-50-25-9, an entity may grant fully vested, non-forfeitable equity instruments that are exercisable by the grantee only after a specified period of time if the terms of the agreement provide for earlier exercisability if the grantee achieves specified performance conditions. Any measured cost of the transaction shall be recognized in the same period(s) and in the same manner as if the entity had paid cash for the goods or services or used cash rebates as a sales discount instead of paying with, or using, the equity instruments. A recognized asset, expense, or sales discount shall not be reversed if a share option and similar instrument that the counterparty has the right to exercise expires unexercised. Pursuant to ASC paragraph 505-50-30-S99-1, if the Company receives a right to receive future services in exchange for unvested, forfeitable equity instruments, those equity instruments are treated as unissued for accounting purposes until the future services are received (that is, the instruments are not considered issued until they vest). Consequently, there would be no recognition at the measurement date and no entry should be recorded.
Related Parties	The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.
Foreign Currency Translation	The measurement currency of the Company is the U.S. dollar. Transactions in foreign currencies are translated at the exchange rate in effect at the transaction date. Monetary assets and liabilities denominated in other than the measurement currency are translated at the exchange rates in effect at the balance sheet date. The resulting exchange gains and losses are recognized in earnings.
Net Earnings (Loss) per Share	Basic and diluted net loss per share information is presented under the requirements of ASC Topic 260, Earnings per Share. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, less shares subject to repurchase. Diluted net loss per share reflects the potential dilution of securities by adding other common stock equivalents, including stock options, shares subject to repurchase, warrants and convertible notes in the weighted-average number of common shares outstanding for a period, if dilutive.

Stock Options and Warrants (Tab

Stock Options and Warrants (Tables)	12 Months Ended
	Mar. 31, 2015
Summary of Stock options	Number of Options Weighted-Average Exercise Price Weighted- Average Remaining Outstanding at as at 3/31/2014 300,000 $ 0.30 9.88 Granted - $ - - Exercised - $ NA NA Cancelled - $ NA NA Outstanding as at 3/31/2015 300,000 $ 0.30 8.88 Exercisable at 3/31/2015 300,000 $ 0.30
Estimated warrants issued in private placement in exchange for cash	Number of warrants Weighted-Average Exercise Price Weighted- Average Remaining Outstanding at as at 3/31/2014 -0- $ -0- -0- Granted 735,000 $ .15 .5 Exercised - $ NA NA Cancelled - $ NA NA Outstanding as at 3/31/2015 735,000 $ 0.15 .5 Exercisable at 3/31/2015 735,000 $ 0.15
Warrant [Member]
Summary of Stock options	Number of warrants Weighted-Average Exercise Price Weighted- Average Remaining Outstanding at as at 3/31/2014 -0- $ -0- -0- Granted 30,000,000 $ .03 5.0 Exercised - $ NA NA Cancelled - $ NA NA Outstanding as at 3/31/2015 30,000,000 $ 0.03 5.0 Exercisable at 3/31/2015 30,000,000 $ 0.03
Estimated warrants issued in private placement in exchange for cash	Number of warrants Weighted-Average Exercise Price Weighted- Average Remaining Outstanding at as at 3/31/2014 -0- $ -0- -0- Granted 916,667 $ .10 5.0 Exercised - $ NA NA Cancelled - $ NA NA Outstanding as at 3/31/2015 916,667 $ 0.10 5.0 Exercisable at 3/31/2015 916,667 $ 0.10

Convertible Debt and Derivati22

Convertible Debt and Derivative liabilities (Tables)	12 Months Ended
	Mar. 31, 2015
Convertible Debt And Derivative Liabilities Tables
Outstanding convertible debt	Principal balance $ 300,000 Receivable-reflected in equity (300,000 ) Balance maturing for the period ending: March 31, 2015 $ -0-

Fair Value Measurement (Tables)

Fair Value Measurement (Tables)	12 Months Ended
	Mar. 31, 2015
Fair Value Measurement Tables
Fair value of the derivative liability	Fair Value Measurements Using Description Total Fair Value at March 31, 2015 Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Derivative liability $ 824,763 $ - $ 824,763 $ - Fair Value Measurements Using Description Total Fair Value at March 31, 2014 Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Derivative liability $ - $ - $ - $ -

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Mar. 31, 2015
Income Taxes Tables
Deferred tax asset	2015 2014 Deferred tax asset: Tax loss carryforward $ 3,163,345 $ 2,987,956 Valuation allowance (3,163,345 ) (2,987,956 ) Net deferred tax asset $ 0 $ 0
The income tax provision	2015 2014 Tax benefit at statutory rates $ 260,759 $ 2,373,407 Change in valuation allowance $ (260,759 ) $ (2,37,3407 ) Net provision for income taxes $ 0 $ 0

Significant Accounting Polici25

Significant Accounting Policies (Details)	95 Months Ended
	Mar. 31, 2015USD ($)
Significant Accounting Policies Details
Losses from operations	$ 12,415,279

Stockholders' Deficit (Details

Stockholders' Deficit (Details Narartive) - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares Issued	162,205,494	135,979,802
Common Stock, Shares Outstanding	162,205,494	135,979,802
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Issued	5,000,000	5,000,000
Preferred Stock, Shares Outstanding	5,000,000	5,000,000
Common Stock Value Issued for Compensation	$ 421,558
Common Stock Shares Issued for Compensation	4,106,014
Total subscription agreement offers	1,470,000
Total subscription agreement offers, Amount	$ 147,000
Total subscription agreement per unit	$ 0.10
Company issued common stock for debt conversions	29,905,505
Company issued common stock for debt conversions , value	$ 507,316
Common stock in exchange for legal services, Amount	$ 14,447
Common stock in exchange for legal services, Shares	344,173
Common stock cancelled	9,600,000
Minimum [Member]
Share price	$ 0.03
Maximum [Member]
Share price	$ 0.19

Stock Options and Warrants (Det

Stock Options and Warrants (Details) - 12 months ended Mar. 31, 2015 - $ / shares	Total
Stock Option [Member]
Number of options, outstanding
Outstanding, beginning of period (in shares)	300,000
Granted
Exercised
Cancelled
Outstanding, end of period (in shares)	300,000
Exercisable, March 31, 2015	300,000
Options, weighted average exercise price
Outstanding, beginning of period (in dollars per share)	$ 0.30
Granted
Exercised
Cancelled
Outstanding, end of period (in dollars per share)	$ 0.30
Exercisable, March 31, 2015	$ 0.30
Weighted Average Remaining Life In Years
Weighted Average Remaining Life (in years) Outstanding	9 years 10 months 17 days
Weighted Average Remaining Life (in years) Exercisable	8 years 10 months 17 days
Warrant [Member]
Number of options, outstanding
Outstanding, beginning of period (in shares)
Granted	30,000,000
Exercised
Cancelled
Outstanding, end of period (in shares)	30,000,000
Exercisable, March 31, 2015	30,000,000
Options, weighted average exercise price
Outstanding, beginning of period (in dollars per share)
Granted	$ 0.03
Exercised
Cancelled
Outstanding, end of period (in dollars per share)	$ 0.03
Exercisable, March 31, 2015	$ 0.03
Weighted Average Remaining Life In Years
Weighted Average Remaining Life (in years) Granted	5 years
Weighted Average Remaining Life (in years) Exercisable	5 years
Subscription agreement [Member]
Number of options, outstanding
Outstanding, beginning of period (in shares)
Granted	735,000
Exercised
Cancelled
Outstanding, end of period (in shares)	735,000
Exercisable, March 31, 2015	735,000
Options, weighted average exercise price
Outstanding, beginning of period (in dollars per share)
Granted	$ 0.15
Exercised
Cancelled
Outstanding, end of period (in dollars per share)	$ 0.15
Exercisable, March 31, 2015	$ 0.15
Weighted Average Remaining Life In Years
Weighted Average Remaining Life (in years) Granted	6 months
Weighted Average Remaining Life (in years) Exercisable	6 months
Convertible Notes[Member]
Number of options, outstanding
Outstanding, beginning of period (in shares)
Granted	916,667
Exercised
Cancelled
Outstanding, end of period (in shares)	916,667
Exercisable, March 31, 2015	916,667
Options, weighted average exercise price
Outstanding, beginning of period (in dollars per share)
Granted	$ 0.10
Exercised
Cancelled
Outstanding, end of period (in dollars per share)	$ 0.10
Exercisable, March 31, 2015	$ 0.10
Weighted Average Remaining Life In Years
Weighted Average Remaining Life (in years) Granted	5 years
Weighted Average Remaining Life (in years) Exercisable	5 years

Stock Options and Warrants (D28

Stock Options and Warrants (Details Narrative) - 12 months ended Mar. 31, 2015 - USD ($)	Total
Stock Option [Member]
Fair value of options	$ 180,000
Expected life	10 years
Risk free interest rate	1.99%
Dividend yield	0.00%
Expected volatility	419.00%
Stock Based Compensation Expense	$ 180,000
Options Vested	300,000
Warrant [Member]
Fair value of options	$ 813,827
Expected life	5 years
Risk free interest rate	1.42%
Dividend yield	0.00%
Expected volatility	207.12%
Stock Based Compensation Expense	$ 813,827
Options Vested	(30,000,000)
Subscription agreement [Member]
Fair value of options	$ 89,432
Expected life	1 year
Risk free interest rate	0.25%
Dividend yield	0.00%
Expected volatility Minimum	185.10%
Expected volatility Maximum	207.49%
Convertible Notes[Member]
Fair value of options	$ 41,250
Expected life	5 years
Risk free interest rate	1.28%
Dividend yield	0.00%
Expected volatility	191.21%

Loans-Related Party (Details Na

Loans-Related Party (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Loans-related Party Details Narrative
Due to Related Parties	$ 558,500	$ 553,000
Interest Expense - Related Party	$ 193,313	$ 35,351

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Notes Payable Details Narrative
Loans due to third parties	$ 430,788	$ 759,854
Issuance of convertible debt	500,000
Forgiveness of debt and interest payable	$ 5,893

Convertible Debt and Derivati31

Convertible Debt and Derivative liabilities (Details)	Mar. 31, 2015USD ($)
Convertible Debt And Derivative Liabilities Details
Receivable-reflected in equity	$ (300,000)
Balance maturing for the period ending: 31-March-15	$ 0

Convertible Debt and Derivati32

Convertible Debt and Derivative liabilities (Details Narrative) - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Convertible Debt And Derivative Liabilities Details Narrative
Convertible note net of the discount	$ 0
Amortization of the discounts	166,568
Derivative liabilities	$ 824,763

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	Mar. 31, 2015	Mar. 31, 2014
Debt derivative liability	$ 824,763
Quoted Prices in Active Markets (Level 1) [Member]
Debt derivative liability
Significant Other Observable Inputs (Level 2) [Member]
Debt derivative liability	$ 824,763
Significant Unobservable Inputs (Level 3) [Member]
Debt derivative liability

Income Taxes (Details)

Income Taxes (Details) - USD ($)	Mar. 31, 2015	Mar. 31, 2014
Deferred tax asset:
Tax loss carryforward	$ 3,163,345	$ 2,987,956
Valuation allowance	(3,163,345)	(2,987,956)
Net deferred tax asset	$ 0	$ 0

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Taxes Details 1
Tax benefit at statutory rates	$ 260,759	$ 2,373,407
Change in valuation allowance	(260,759)	(2,373,407)
Net provision for income taxes	$ 0	$ 0

Income Taxes (Details Narrative

Income Taxes (Details Narratives) - Mar. 31, 2015 - USD ($)	Total
Income Taxes Details Narratives
Net operating loss carry-forwards	$ 9,304,000
Net operating loss carry-forwards expire	2,025

Earnings Per Share - Potentia37

Earnings Per Share - Potential Dilutive Securities (Details Narratives) - USD ($)	Mar. 31, 2015	Mar. 31, 2014
Earnings Per Share - Potential Dilutive Securities Details Narratives
Potentially dilutive securities	$ 34,291,724	$ 0

Uncategorized Items - ecry-2015

Label	Element	Value
Convertible Debt	us-gaap_ConvertibleDebt	$ 300,000